The lawsuit filed by the Pharmaceutical Research and Manufacturers of America and co-plaintiffs against the federal government over the Medicare price negotiation program has run aground over a jurisdictional issue that is likely to come up again in similar industry lawsuits.
The issue has to do with a legal precedent regarding jurisdiction that states parties challenging a Medicare law or regulation...







